Neurology Central

Elevating neuregulin 1 could alleviate Alzheimer’s symptoms

0
Researchers from the Salk Institute’s Clayton Foundation Laboratories for Peptide Biology (San Diego, CA, USA) have utilized rodent models to investigate the effects of increased hippocampal neuregulin 1 (NRG1) on Alzheimer’s disease (AD) symptoms and neuropathology. Utilizing a lentiviral vector system, the team demonstrated that elevated NRG1 may improve cognitive deficits and neuropathology in AD.
To view restricted content, please:
Share:

Leave A Comment